BeiGene (HKG:6160, SHA:688235) granted share options and restricted share units to its employees and directors under its 2016 share option and incentive plan, according to a Friday filing with the Hong Kong stock exchange.
The biopharmaceutical company granted 22,713 American depositary shares to 12 employees.The options are equivalent to 295,269 underlying shares, and will vest in 10 years, the filing said.
It also granted 90,542 restricted share units in ADSs to 223 recipients, equivalent to 1,177,046 underlying shares, according to the filing.
Price (HKD): $147.70, Change: $+7.0, Percent Change: +4.98%
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。